NERV minervaneurosciences.com: Accounting Value per Share
Minerva Neurosciences utilizes bioinformatics to discover drug formulas, which confirms the current book value of the stock within its historical trend on the GURU.Markets chart, where the value -4.51 reflects the metric balance. The business model relies on outsourcing production and clinical trials. The company is currently depleting its existing reserves due to the prolonged wait for drug approval.
minervaneurosciences.com - analytical breakdowns and key metrics (NERV)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:Minerva Neurosciences Corp, NERV
Searching for fundamentally resilient assets requires an analysis of net assets, excluding market speculation. The book value per share is calculated as the difference between all assets and liabilities divided by the number of shares, which determines the actual asset backing of each stake. For Minerva Neurosciences (NERV), amid regulatory failures and loss of market share, this chart serves as an indicator of the business's residual value upon liquidation.
Competitor analysis for Minerva Neurosciences
Net Assets per Single Share Biogen Corp (BIIB)|Neurocrine Corp (NBIX) - Accounting Value of a Share|Regencell Bioscience (RGC) - Accounting Value per Share|AXSM (axsome.com) - Net Assets per Single Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|Net Assets per Single Share PRAX|Accounting Value per Share anavex.com|CBLL (CeriBell) - Book Value per Share|Net Assets per Share PRTA (Prothena Corporation)|ALEC - Net Assets per Single Share|Equity per Share Annexon Biosciences Inc. ANNX|OMER (Omeros Corp.) - Book Value per Share|NGNE: Net Asset Value per Share|Net Assets per Single Share AC Immune SA ACIU|Accounting Value of a Share Voyager Therapeutics Inc|Accounting Value per Share Neumora Therapeutics Inc|Net Assets per Single Share Scilex Holding Company, Inc.|Book Value per Share TVGN|Book Value per Share alphacognition.com ACOG|Accounting Value per Share Cognition Therapeutics|Inhibikase Therapeutics Inc - Accounting Value of a Share|Cassava (SAVA) - Net Assets per Single Share|ASRT - Equity per Share|Book Value per Share COYA|Net Asset Value per Share Vistagen|OVID (Ovid Therapeutics Inc) - Accounting Value per Share|Book Value per Share ABOS|CervoMed Inc (CRVO) - Net Assets per Single Share|Accounting Value of a Share ATHE (alteritytherapeutics.com)|CLNN: Net Assets per Single Share|PepGen Inc - Net Asset Value per Share|Net Assets per Single Share JUNS (Jupiter Neurosciences Inc)|RLMD - Net Assets per Share|ANVS (Annovis Bio Corp) - Book Value per Share|Grace Therapeutics (GRCE) - Accounting Value per Share|AIFF: Book Value per Share|Net Assets per Share ANEW Medical, Inc.|NeuroSense Therapeutics - Book Value per Share|Net Asset Value per Share RVPH (Reviva Pharmaceuticals Holdings Inc.)|MTVA - Net Assets per Single Share|Equity per Share NeurAxis Inc NRXS|HSDT: Book Value per Share|PASG - Accounting Value per Share|Book Value per Share NEUP|ATHA (Athira Pharma Inc) - Net Asset Value per Share|ADXN: Net Assets per Single Share|Net Assets per Share ALZN|Net Assets per Single Share Cyclerion Therapeutics CYCN|Equity per Share protagenic.com (PTIX)|KTTA: Book Value per Share|Cortigent Inc - Net Asset Value per Share|Net Assets per Single Share Avenue Therapeutics, Inc (ATXI)|BrainStorm Cell Therapeutics Inc. (BCLI) - Accounting Value of a Share|Cara Therapeutics, Inc. (CARA) - Accounting Value per Share|CHRO (chromocell.com) - Net Assets per Single Share|Net Assets per Single Share Eliem Therapeutics, Inc. (ELYM)|Equity per Share Intra-Cellular|Longboard Pharma - Book Value per Share|Net Asset Value per Share Marinus Pharma MRNS|Accounting Value per Share NKGN (NKGen Biotech, Inc.)|neurobopharma.com - Book Value per Share|Net Assets per Single Share Sage Therapeutics (SAGE)|SNPX: Accounting Value of a Share|Net Assets per Single Share TRVN|VIGL (Vigil Neuroscience, Inc.) - Net Asset Value per Share|Net Assets per Single Share WENA|Accounting Value per Share cerevel.com